Helping Medical Laboratories Add Value to Health Systems, Providers, and Payers by Moving from Clinical Lab 1.0 to Clinical Lab 2.0

November workshop to teach Clinical Lab 2.0 to forward-thinkers among clinical laboratories, IVD manufacturers, and lab IT vendors offered many examples where clinical laboratory diagnostics can add value and improve patient outcomes DATELINE: ALBUQUERQUE, New Mexico—Here in this mile-high city, a special Project Santa Fe Workshop devoted to teaching the principles of Clinical Lab 2.0 attracted an impressive roster of innovators and forward-thinkers in clinical laboratory medicine. In...

Helping Medical Laboratories Add Value to Health Systems, Providers, and Payers by Moving from Clinical Lab 1.0 to Clinical Lab 2.0

November workshop to teach Clinical Lab 2.0 to forward-thinkers among clinical laboratories, IVD manufacturers, and lab IT vendors offered many examples where clinical laboratory diagnostics can add value and improve patient outcomes DATELINE: ALBUQUERQUE, New Mexico—Here in this mile-high city, a special Project Santa Fe Workshop devoted to teaching the principles of Clinical Lab 2.0 attracted an impressive roster of innovators and forward-thinkers in clinical laboratory medicine. In...

Disruptive Forces Reshaping Australia’s Healthcare System, with Consequences for Hospitals, Physicians, and Clinical Pathology Laboratories, Outlined at First Annual ‘Disruption in Healthcare Conference’

Topics discussed ranged from ongoing cutbacks in funding for healthcare services, and integration of clinical care to growing use of genetic testing in support of precision medicine DATELINE: Sydney, NSW, Australia—There were 200 leaders in healthcare, medicine, and pathology gathered here last Wednesday to explore a hot topic: the unfolding disruption to healthcare in Australia. The themes of the conference will be familiar to Dark Daily readers across the globe. These themes included: •...

IFCC WorldLab 2011 Conference in Berlin Provides Look at Developing Trends in Clinical Laboratory Testing Products

IVD manufacturers often introduce their newest technologies in Europe before the United States DATELINE: BERLIN, GERMANY: With so many changes happening to clinical pathology laboratory testing in developed nations around the world, there is keen interest in evolving technologies, along with new medical laboratory instruments and automation products that clinical biochemists and pathologists will use, in the near future, to improve the quality of the clinical laboratory testing services they...

Clinical Laboratory Company Quest Diagnostics Agrees to Acquire Celera Corp. for $657 Million

Celera is not a medical laboratory, but develops biomarkers and molecular diagnostics tests For the second time since the New Year, Quest Diagnostics Incorporated (NYSE:DGX) has announced an acquisition. Last Friday, Quest Diagnostics said it had agreed to purchase Celera Corp. (NASDAQ:CRA) for a purchase price that Reuters reported to be $657 million. What makes this acquisition different from those typically done by Quest Diagnostics and its major competitor, Laboratory Corporation of...